The Science of Cannabinoids: Where Are We Now

This presentation will help the following ANCOR members: State Associations, Agencies, Administrative staff, Nurses, QIDPs, and DSPs.

Join us for an exploration of cannabinoids with Michael Faithe, PharmD, in his presentation “The Science of Cannabinoids: Where are We Now.” As an Associate Director of Payer, Value, and Outcomes (PVO) at Jazz Pharmaceuticals, Michael leads scientific engagement across Jazz therapeutic areas, focusing on marketed and pipeline products. Michael will discuss “The Science of Cannabinoids,” to stay current on the science, policy, and terminology of these fascinating molecules.

We will also discuss the utilization of cannabinoids in the I/DD space. In this presentation, you will learn:

• What Cannabinoids Are: Discover the nature of cannabinoids, their sources, and their interactions with the body’s endocannabinoid system.
• Key Cannabinoids: Explore prominent cannabinoids like THC and CBD, and their distinct effects.
• Evidence-Based Approach to Cannabinoid Science: Delve into evidence required for drug regulatory approval.
• Current Legal and Regulatory Landscape: Get an overview of the evolving legal status of cannabinoids and the challenges faced in research.
• Consumer Health and Safety: Learn about the safety considerations and cannabinoids in consumer health.

Presenters